Top Abstract Purchase Related
Home
>
Node
>
Subnode

The use of BCG for the prevention of recurrence of superficial bladder tumors: 10 year's experience

Sampalmieri, G.

Rivista Europea Per le Scienze Mediche e Farmacologiche 18(2): 67-71

1996

ISSN/ISBN: 0392-291X
PMID: 9213845
Document Number: 465467
The aim of this study was evaluate the usefulness of intravescical administration of Bacillus of Calmette Guerin (BCG) in patients with superficial bladder cancer. The BCG, an immunostimulating agent, has been introduced in routine clinical use; according to the international literature, it is reported to offer better result than the above-mentioned drugs. A retrospective analysis was made of 210 patients who had undergone a complete TUR for superficial bladder tumor. The irritative symptoms and systemic effects are acceptables considering the benefit of the BCG. The results are of great interest and encourage us to continue this study to confirm therapeutic strength.

Document emailed within 1 workday
Secure & encrypted payments

Maier, U.; Kuber, W. 1983: Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors Fortschritte der Medizin 101(12): 535-540
Unda Urzaiz, M.; Zubiaur Líbano, C.; Pérez Fernández, A.; Iriarte Soldevilla, J.I.; Flores Corral, N. 1990: Adriamycin versus ftorafur in the prevention of recurrence of superficial carcinoma of the bladder Archivos Espanoles de Urologia 43(2): 143-146
Yoshida, O.; Miyakawa, M.; Watanabe, H.; Mishina, T.; Okajima, E.; Hirao, Y.; Matushima, M.; Nihira, H.; Nakatsu, H. 1986: Prophylactic effect of etretinate on the recurrence of superficial bladder tumors--results of a randomized control study Hinyokika Kiyo. Acta Urologica Japonica 32(9): 1349-1358
Tsujihashi, H.; Akiyama, T.; Kurita, T.; Iguchi, M.; Uejima, S.; Kataoka, K.; Minakata, S.; Kitagawa, M.; Sangen, H. 1988: An experience of OK-432 intradermal administration in superficial bladder tumors Hinyokika Kiyo. Acta Urologica Japonica 34(12): 2111-2114
Moyano Calvo, J.L.; Teba del Pino, F.; Sanz Sacristán, J.; Fernández Arjona, M.; Arellano Gañan, R.; Rabadán Ruiz, M.; Herrero Torres, L.; Melón Rey, F.J.; Pereira Sanz, I. 1995: Immunoprophylaxis of superficial tumors of the bladder with interferon alfa-2b. our experience Archivos Espanoles de Urologia 48(1): 55-59
Moyano Calvo, J.L.; Ortíz Gámiz, A.; Romero Díaz, A.; Sánchez Sánchez, E.; Blanco Palenciano, E.; Arribas Rodríguez, J.M.; Castiñeiras Fernández, J. 1999: The prevention of stage-T1 superficial bladder tumors with 27 mg. of BCG weekly over 6 weeks Archivos Espanoles de Urologia 52(7): 760-768
Moyano Calvo, J.L.; Sanz Sacristán, J.; Teba del Pino, F.; Fernández Arjona, M.; Peinado Ibarra, F.; Mélon Rey, F.; Herrero Torres, L.; Rabadán Ruiz, M.; Arellano Gañán, R.; Albacete Almodóvar, P. 1995: Calmette-Guerin bacillus in the prophylaxis of superficial bladder tumors. our experience and our doubts Archivos Espanoles de Urologia 48(8): 791-795
Bach, D.; Romics, I.; Rüssel, C. 1992: Clinical experience with BCG immune prevention in superficial bladder cancer Der Urologe. Ausg. a 31(5): 296-301
Wart, F.; Naôme, D. 1987: Value of peroperative endocavitary echography in the staging of superficial tumors of the bladder. Personal experience in 41 cases Acta Urologica Belgica 55(4): 647-651
Wetzel, O.; Glemain, P.; Bouchot, O.; Guillonneau, B.; Baron, M.; Buzelin, J.M.; Auvigne, J. 1993: The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 3(4): 595-607
Mauroy, B.; Bonnal, J.L.; Prevost, B.; Chive, M.; Lhotellier, V.; Sozanski, J.P.; Vanseymortier, L.; Stefaniak, X. 1999: Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(1): 69-80
Colombo, R. 2006: Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors European Urology 50(2): 233-234
Koch, M.; Hill, G.B.; McPhee, M.S. 1986: Factors affecting recurrence rates in superficial bladder cancer Journal of the National Cancer Institute 76(6): 1025-1029
Mokos, I.; Jakić-Razumović, J.; Mareković, Z.; Pasini, J. 2006: Association of cyclooxygenase-2 immunoreactivity with tumor recurrence and disease progression in superficial urothelial bladder cancer Tumori 92(2): 124-129
Nonomura, N.; Nishimura, K.; Okuyama, A.; Miki, T.; Kishimoto, T.; Kiyohara, H.; Wakatsuki, A.; Fujioka, H.; Kuroda, H.; Nakano, E.; Takeyama, M.; Koide, T.; Yamaguchi, S. 2001: Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time Hinyokika Kiyo. Acta Urologica Japonica 47(5): 315-319
Huland, H.; Otto, U. 1983: Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Results of a controlled, prospective study in 58 patients European Urology 9(2): 84-86
Chopin, D.K. 1997: Treatment of superficial bladder tumors La Revue du Praticien 47(4): 382-387
Gattegno, B.; Chopin, D. 2001: Management of superficial bladder tumors Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 11(5): 1161-1174
Biserte, J.; Rigot, J.M.; Mauroy, B.; Mazeman, E. 1989: Intravesical mitomycin C and superficial bladder tumors Progress in Clinical and Biological Research 303: 411-415
Matsumura, Y. 1989: Intravesical chemotherapy of superficial bladder tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(2): 193-198